For over 40% of uveal melanomas, MAPK activation is driven by mutation of GNAQ[12], a gene that encodes for the alpha subunit of a heterotrimeric G protein complex (αβγ) that mediates signaling between G-protein–coupled receptors (GPCRs) and downstream effectors. This evidence concerns the gene GNAQ and uveal melanoma.